Combination therapy of prednisone and ACE inhibitor versus ACE-inhibitor therapy alone in patients with IgA nephropathy: a randomized controlled trial.
about
Immunosuppressive agents for treating IgA nephropathyNon-immunosuppressive treatment for IgA nephropathyIgA nephropathy with minimal change disease.Effects of cyclosporin A therapy combined with steroids and angiotensin converting enzyme inhibitors on childhood IgA nephropathyOptimal proteinuria target for renoprotection in patients with IgA nephropathy.Steroids in the treatment of IgA nephropathy to the improvement of renal survival: a systematic review and meta-analysis.Corticosteroid therapy in IgA nephropathy.Addition of azathioprine to corticosteroids does not benefit patients with IgA nephropathy.Aberrantly glycosylated IgA1 as a factor in the pathogenesis of IgA nephropathyRandomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy.Predicting the risk for dialysis or death in IgA nephropathy.Long-term results of a randomized controlled trial in childhood IgA nephropathy.Mycophenolate mofetil therapy for steroid-resistant IgA nephropathy with the nephrotic syndrome in childrenLong-term kidney survival analyses in IgA nephropathy patients under steroids therapy: a case control study.Tacrolimus restores podocyte injury and stabilizes the expression of Cabin1 in 5/6 nephrectomized rats.Pathologic predictors of renal outcome and therapeutic efficacy in IgA nephropathy: validation of the oxford classification.Corticosteroids in IgA Nephropathy: A Retrospective Analysis from the VALIGA Study.Corticosteroid Treatment Influences TA-Proteinuria and Renal Survival in IgA Nephropathy.Use of low-dose sulodexide in IgA nephropathy patients on renin-angiotensin system blockadesTacrolimus combined with low-dose corticosteroids is an effective and safe therapeutic option for refractory IgA nephropathy.Progression of IgA nephropathy under current therapy regimen in a Chinese population.Glomerular diseases: emerging tests and therapies for IgA nephropathyPharmacogenomics: a new paradigm to personalize treatments in nephrology patients.Treatment of IgA nephropathy: an update.Treatment of IgA nephropathy and Henoch-Schönlein nephritis.Effect of Oral Methylprednisolone on Clinical Outcomes in Patients With IgA Nephropathy: The TESTING Randomized Clinical Trial.Emerging therapies in immunoglobulin A nephropathy.Treatment of IgA nephropathy with renal insufficiency.Highlights of the 2015 ERA-EDTA Congress--glomerular diseases.Corticosteroids in IgA Nephropathy: Lessons from Recent Studies.Is there a role for immunosuppression in immunoglobulin A nephropathy?Pro: STOP immunosuppression in IgA nephropathy?Role of immunosuppressive therapy and predictors of therapeutic effectiveness and renal outcome in IgA nephropathy with proteinuria.Corticosteroids in patients with IgA nephropathy and severe chronic renal damage.Treatment of resistant glomerular diseases with adrenocorticotropic hormone gel: a prospective trial.A Randomized, Controlled Trial of Rituximab in IgA Nephropathy with Proteinuria and Renal Dysfunction.Severe Adverse Effects Associated With Corticosteroid Treatment in Patients With IgA Nephropathy.Effects of Two Immunosuppressive Treatment Protocols for IgA Nephropathy.IgA nephropathy in Greece: data from the registry of the Hellenic Society of Nephrology.Comparison of inhibitors of renin-angiotensin-aldosterone system (RAS) and combination therapy of steroids plus RAS inhibitors for patients with advanced immunoglobulin A nephropathy and impaired renal function.
P2860
Q24188035-DEBFC25A-4FE0-4641-B6E4-D04DE2A628C9Q24235956-22941BBB-3CD3-4742-AEA0-0557F550B216Q33715857-98E1A014-740B-498E-99E9-B0DAA9B25F7FQ33807241-BC8C9D0C-749C-41DE-B841-E7922ADA543CQ33864287-4DFA493D-9A28-4FDB-89A7-5B86340F59B0Q33886910-E832CC06-6B7A-434D-B8E1-8BDC97180395Q34249313-D831F1D8-B209-4EEE-A324-B14E31E7AF87Q34455482-589F396E-9926-4CB1-B450-A0A8B5240A44Q34557198-E32DFEC0-C6FF-4DD5-8A3B-EBD8A8834F5CQ34658876-AA1FAA78-E1E4-42CD-B3C1-7F6F217A61C4Q34726899-A8376A6B-BF43-401B-B66C-ED36259EFC6AQ35030576-15E02368-B7D8-4C59-A3E2-EE188EA62B8AQ35657080-38CAB7EA-7374-4A57-A186-B59A1E4FDE47Q35743170-A80D1D95-ED27-4FD1-A737-747054B74FE6Q35932322-559F0915-635E-4673-8355-A8BDE2E3D6D2Q35983485-87AABE84-C4A1-4CA5-BCC2-FBBE5BE4C9F6Q36003136-52C399AD-23BE-4F03-86CF-5828E6A5B016Q36077744-0616B611-C5C8-4746-A04E-83BBD3F61F99Q36471767-B9C05CEE-5D70-4F31-9B4A-4758540B5D42Q37205233-5D8761EC-0BD8-4104-8D8E-1FBFD8E87BBFQ37621529-83479A4A-8E44-4155-81CF-70F862C5318DQ37621563-70460047-6643-45CE-BD40-134C7AFF49A6Q37646842-D0456C46-021E-4F9F-AF67-19D5D8FC7318Q37939849-D5133757-8A39-48E9-9395-0C5A53C96FD4Q38094888-AB839DD6-6892-4EB1-82DB-5CED283178E1Q38372995-D9343A70-F0D8-4C8D-BB06-A3CAE1AE6D1EQ38511505-345E62EF-D577-4859-9405-C269B2EC6732Q38689787-78538B40-D057-4AA2-9E3B-0C83EA45501DQ38695675-93E71E3E-ADFE-46FB-99D6-073C23C4CDD1Q38817381-47D0F6ED-613D-49A0-B00C-14E9C3929BD3Q39229309-A4E79C3C-8AFE-4B4A-BE0C-CE375854207FQ39497940-2F9EB6E3-1124-4D20-A783-518A7AA3EE9DQ40428635-CFC8F7F3-187F-468A-A8DA-54616DC97A78Q41816657-3FA33801-C4C8-4A8F-ADDC-8894494FCDB2Q42654718-9B3E6735-400E-4B8B-8C1F-7D3FD82B0E7EQ46606282-FB7D1D30-F3F6-46D4-9D67-509037EF6F72Q47107237-802B05F6-22C5-4102-B932-953B80EFBA8AQ47773361-956853A3-5FC1-4777-BACD-E5A708EF3FD0Q49477908-BB37236C-9158-450D-B6B0-71112A82708EQ50523800-51DEC470-1294-482F-AACD-F553AD81B97D
P2860
Combination therapy of prednisone and ACE inhibitor versus ACE-inhibitor therapy alone in patients with IgA nephropathy: a randomized controlled trial.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Combination therapy of prednis ...... a randomized controlled trial.
@en
Combination therapy of prednis ...... a randomized controlled trial.
@nl
type
label
Combination therapy of prednis ...... a randomized controlled trial.
@en
Combination therapy of prednis ...... a randomized controlled trial.
@nl
prefLabel
Combination therapy of prednis ...... a randomized controlled trial.
@en
Combination therapy of prednis ...... a randomized controlled trial.
@nl
P2093
P1476
Combination therapy of prednis ...... a randomized controlled trial.
@en
P2093
Ajay K Singh
Guangtao Li
Haiyan Wang
Hong Zhang
Jicheng Lv
Yuqing Chen
P356
10.1053/J.AJKD.2008.07.029
P577
2008-10-19T00:00:00Z